CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Ciaffoni Joseph President and CEO | Grant or award | +119,000 | 394,000 | ||
| 2024-02-12 | Ciaffoni Joseph President and CEO | Grant or award | +179,734 | 573,734 | ||
| 2024-02-12 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −47,445 | $33.70 | $1.6M | 526,289 |
| 2024-02-12 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −81,422 | $33.70 | $2.7M | 444,867 |
| 2023-12-21 | Ciaffoni Joseph President and CEO | Exercise or conversion 10b5-1 | +4,357 | $21.34 | $93K | 279,357 |
| 2023-12-21 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −4,357 | $30.38 | $132K | 275,000 |
| 2023-12-21 | Ciaffoni Joseph President and CEO | Exercise or conversion · Stock Option (Right to Purchase) 10b5-1 | −4,357 | 16,875 | ||
| 2023-12-20 | Ciaffoni Joseph President and CEO | Exercise or conversion 10b5-1 | +26,454 | $21.34 | $565K | 301,454 |
| 2023-12-20 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −26,454 | $30.40 | $804K | 275,000 |
| 2023-12-20 | Ciaffoni Joseph President and CEO | Exercise or conversion · Stock Option (Right to Purchase) 10b5-1 | −26,454 | 21,232 | ||
| 2023-12-19 | Ciaffoni Joseph President and CEO | Exercise or conversion 10b5-1 | +14,516 | $21.34 | $310K | 289,516 |
| 2023-12-19 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −14,516 | $30.03 | $436K | 275,000 |
| 2023-12-19 | Ciaffoni Joseph President and CEO | Exercise or conversion · Stock Option (Right to Purchase) 10b5-1 | −14,516 | 47,686 | ||
| 2023-12-18 | Ciaffoni Joseph President and CEO | Exercise or conversion 10b5-1 | +27,798 | $21.34 | $593K | 302,798 |
| 2023-12-18 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −27,798 | $30.04 | $835K | 275,000 |
| 2023-12-18 | Ciaffoni Joseph President and CEO | Exercise or conversion · Stock Option (Right to Purchase) 10b5-1 | −27,798 | 62,202 | ||
| 2023-06-02 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −30,272 | $21.58 | $653K | 276,000 |
| 2023-06-02 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −1,000 | $22.25 | $22K | 275,000 |
| 2023-06-01 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −31,272 | $22.09 | $691K | 306,272 |
| 2023-05-31 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −31,272 | $21.87 | $684K | 337,544 |
Page 1 of 6 · 116 trades